Filing Flows › Apyx Medical (APYX) › Q2 2025
Apyx Medical (APYX) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
Apyx Medical (APYX) reported revenue of $11.4M for the second quarter 2025 (Q2 2025), -6% from a year earlier and +21% from the quarter before. Operating margin was -22.6%, net loss $3.7M (32.9% of revenue).
Apyx Medical, Q2 2025: revenue $11.4M (-6% year over year), operating margin -22.6%, net loss $3.7M, operating cash flow −$1.2M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.4M | +21% | -6% |
| Operating profit | −$2.6M | — | — |
| Net earnings | −$3.7M | — | — |
| Operating cash flow | −$1.2M | — | — |
What changed
Revenue was $11.4M in Q2 2025, down 6% year over year and up 21% from the previous quarter.
Gross margin was 62.3%, up 0.6 points from a year earlier. Operating costs exceeded revenue by $2.6M, an operating margin of -22.6%. Operating expenses fell 26% while revenue fell 6%. The quarter ended with a net loss of $3.7M, narrower than the previous quarter's $4.2M loss.
Operating cash flow was −$1.2M. Non-cash charges added back $132K of depreciation and amortization and $520K of share-based compensation. Working capital and other items added $1.9M. Capital expenditures of $265K exceeded it, leaving free cash flow of −$1.5M.
Questions
What was Apyx Medical's revenue in the second quarter 2025?
Apyx Medical (APYX) reported revenue of $11.4M for the second quarter 2025 (Q2 2025), -6% from a year earlier and +21% from the quarter before.
Was Apyx Medical profitable in the second quarter 2025?
Operating loss was $2.6M (-22.6% of revenue) and net loss $3.7M.
Source: Apyx Medical 10-Q on SEC EDGAR.